Picture of a human melanoma cell line growing in tissue culture

RNA therapies


  • targeting long non-coding RNA
  • using nucleic acid based-drugs

RNA biomarkers


  • biomarker discovery
  • biomarker signature identification
  • development of clinical-grade test


Deploying the transcriptome

At Biogazelle we are dedicated to deploy the transcriptome through excellence in science and technology.

We carefully select the best analytical platforms to offer customized RNA gene expression solutions to develop RNA targeted biomarkers and nucleic acid-based therapies.

We are fascinated by the complexity of the non-coding RNA world.

ISO 17025 logo

Biogazelle's solutions

Biomarker discovery

Our lab activities support the life science market at every level of the entire process: from RNA sequencing based discovery to PCR validation of biomarkers, from experiment design to result interpretation, from PCR assay design to research-use-only kits.

Learn more

RNA therapies

Using our proprietary and integrative target selection strategy, we prioritize long non-coding RNA genes as therapeutic targets in cancer. We combine large scale in vitro screens with preclinical animals models to develop nucleic acid based therapies.

Learn more


qbase+ is the most powerful and flexible real-time PCR data analysis software.

It's developed by experts for qPCR users belonging to all experience levels.

The software is packed with unique features to achieve high-quality results in a user-friendly manner.

Learn more

Current topics


lncRNA qPCR assays designed by Biogazelle, back in 2011! https://t.co/igsB8jL0CZ
12/07/2016 - 22:47
Getting the most out of your samples – microRNA enrichment by depleting abundant undesirable small RNAs in biofluids https://t.co/lffD08vzpZ
08/07/2016 - 15:51